-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$166.621.26% Upside
Recent Analyst Forecasts and Stock Ratings
Quest Diagnostics Incorporated Frequently Asked Questions
-
What analysts cover Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated has been rated by research analysts at Citigroup, Leerink Partners, Barclays, Robert W. Baird, CFRA, Truist Financial in the past 90 days.